title: Anticonvulsant efficacy of drugs with cholinergic and/or glutamatergic antagonism microinfused into area tempestas of rats exposed to soman.
abstract: A group of antiparkinson drugs (benactyzine, biperiden, caramiphen, procyclidine, and trihexyphenidyl) has been shown to possess both anticholinergic and antiglutamatergic properties, making these agents very well suited as anticonvulsants against nerve agents. The first purpose of this study was to make a comparative assessment of the anticonvulsant potencies of the antiparkinson agents when microinfused (1 microl) into the seizure controlling area tempestas (AT) of rats 20 min before subcutaneous injection of soman (100 microg/kg). The second purpose was to determine whether cholinergic and/or glutamatergic antagonism was the effective property. The results showed that only procyclidine (6 microg) and caramiphen (10 microg) antagonized soman-induced seizures. Cholinergic, and not glutamatergic, antagonism was likely the active property, since atropine (100 microg), and scopolamine (1 microg) caused anticonvulsant effects, whereas MK-801 (1 microg), and ketamine (50 microg) did not. Soman (11 nmol) injected into AT resulted more frequently in clonic convulsions than full tonic-clonic convulsions. AT may serve as both a trigger site for soman-evoked seizures and a site for screening anticonvulsant potencies of future countermeasures.
authors: Norwegian Defence Research Establishment, Protection Division, P.O. Box 25, 2027 Kjeller, Norway. trond.myhrer@ffi.no
authors: Trond
authors: T
authors: Myhrer
authors: Siri
authors: S
authors: Enger
authors: Pål
authors: P
authors: Aas
mesh_terms: D000818:Animals; D000927:Anticonvulsants / Q000008:administration & dosage / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects*; D018680:Cholinergic Antagonists / Q000494:pharmacology*; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D011950:Receptors, Cholinergic / Q000187:drug effects*; D017470:Receptors, Glutamate / Q000187:drug effects*; D012999:Soman / Q000633:toxicity*
chemical_list: D000927:Anticonvulsants; D018680:Cholinergic Antagonists; D018691:Excitatory Amino Acid Antagonists; D011950:Receptors, Cholinergic; D017470:Receptors, Glutamate; D012999:Soman
references: Brain Res. 2000 Aug 25;874(2):123-30
references: 10960596
references: Epilepsia. 1988;29 Suppl 2:S15-34
references: 2844521
references: Brain Res Bull. 1989 Jul-Aug;23(1-2):145-8
references: 2553217
references: Eur J Pharmacol. 2005 Jun 15;516(3):227-34
references: 15967427
references: Adv Clin Chem. 2004;38:151-216
references: 15521192
references: Eur J Pharmacol. 1993 Feb 16;231(3):485-8
references: 8449241
references: Neurosci Biobehav Rev. 1991 Fall;15(3):349-62
references: 1683477
references: Neurotoxicology. 2002 May;23(1):7-17
references: 12164550
references: Neurosci Biobehav Rev. 1993 Summer;17(2):203-15
references: 8515903
references: J Biomed Sci. 1999 Mar-Apr;6(2):86-96
references: 10087439
references: Epilepsia. 1991 Sep-Oct;32(5):604-15
references: 1915166
references: Eur J Pharmacol. 2001 Oct 12;428(3):323-30
references: 11689190
references: Exp Neurol. 1986 Sep;93(3):546-56
references: 3743700
references: Brain Res. 1987 Dec 1;435(1-2):123-37
references: 3427447
references: J Comp Neurol. 2001 Jun 4;434(3):289-307
references: 11331530
references: Neurotoxicology. 1999 Aug;20(4):551-9
references: 10499354
references: J Neurosci. 1998 May 15;18(10):3897-908
references: 9570817
references: J Pharm Pharmacol. 1998 Nov;50(11):1299-305
references: 9877318
references: J Pharmacol Exp Ther. 1995 Jul;274(1):353-60
references: 7616420
references: Eur J Pharmacol. 1990 Sep 18;189(2-3):135-42
references: 2253700
references: Basic Clin Pharmacol Toxicol. 2006 Feb;98(2):184-91
references: 16445593
references: Neurosci Lett. 1992 May 11;139(1):104-7
references: 1357600
references: Toxicol Appl Pharmacol. 2004 May 1;196(3):327-36
references: 15094303
references: Nature. 1985 Oct 17-23;317(6038):623-5
references: 4058572
references: Neurotoxicology. 2003 Jun;24(3):357-67
references: 12782101
references: Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):249-53
references: 7667336
references: Drug Chem Toxicol. 1984;7(6):605-24
references: 6534735
references: Eur J Pharmacol. 2002 Aug 9;449(3):239-43
references: 12167465
references: Acta Medica (Hradec Kralove). 2003;46(3):101-7
references: 14677718
references: Neurosci Biobehav Rev. 1997 Sep;21(5):559-79
references: 9353792
references: Epilepsy Res Suppl. 1996;11:17-43
references: 9294726
references: J Pharmacol Exp Ther. 1988 Dec;247(3):1025-31
references: 2849655
references: Arch Toxicol. 2006 Aug;80(8):502-7
references: 16525814
references: Prog Drug Res. 2000;54:152-89
references: 10857388
references: Toxicol Sci. 2003 Sep;75(1):108-16
references: 12832655